New pill hopes to tame relapsed blood cancers in early trial
NCT ID NCT05347225
First seen May 12, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This early-phase study tests an oral drug called MK-1026 in 12 Chinese adults with blood cancers that have returned or not responded to prior treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors. This is not a cure; the drug aims to control the disease, and participants may need ongoing treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Provincial People's Hospital-hematology department ( Site 1002)
Guangzhou, Guangdong, 510080, China
-
Henan Cancer Hospital-hematology department ( Site 1003)
Zhengzhou, Henan, 450008, China
-
Hunan Cancer Hospital ( Site 1004)
Changsha, Hunan, 410013, China
-
Institute of hematology&blood disease hospital-Hematology ( Site 1001)
Tianjin, Tianjin Municipality, 301636, China
-
SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal medicine ( Site 1007)
Guangzhou, Guangdong, 511400, China
Conditions
Explore the condition pages connected to this study.